Pharmaceutical company Roche has revealed that several late-stage trials run for its multiple sclerosis drug, Ocrelizumab, have proven to be more promising and...
Tag - MS
A new drug formulated for treating patients with multiple sclerosis (MS) is capable of cutting down relapses by nearly 50% more than what the existing standard...
